The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
SARS-CoV-2 회복기 혈청의 중화 활성 및 RBD 결합에 대한 스파이크 N501Y 돌연변이의 영향
Article
[키워드] 95% CI
Amino acid
amino acids
ANOVA
Anti-RBD IgG
Anti-S1
antibody
Antibody binding
assays
B.1.1.7
B.1.351
binding
binding domain
clinician
collected
convalescent sera
convalescent serum
COVID-19
COVID-19 patient
determine
enzyme immunoassay
evaluated
geometric
geometric mean
geometric mean titer
GMT
Hong Kong
IgG
isolates
K417N
Lineage
mean difference
Michael
microneutralization
N501Y
N501Y mutation
neutralization
Neutralizing activity
neutralizing antibody
Neutralizing antibody Spike protein receptor binding domain
NSP2
one-way ANOVA
Patient
positive
Protein
RBD
RBD binding
Receptor binding
Receptor binding domain
recovered COVID-19 patient
reduced
Richard
SARS-CoV-2
SARS-CoV-2 isolate
SARS-CoV-2 lineage
SARS-CoV-2 N501Y variant B.1.1.7
sensitivity
sera
serum
service
significantly
spike
Spike protein
Spike receptor binding domain
Spread
statistically
susceptibility
symptom onset
tested
variant
variants
virus
virus variant
virus variants
viruses
VoC
VOC.
was determined
wild-type
[DOI] 10.1016/j.ebiom.2021.103544 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.ebiom.2021.103544 PMC 바로가기 [Article Type] Article